McKesson(US:MCK) ZACKSยท2025-07-08 23:01Company Performance - McKesson's stock closed at $724.11, down 1.53% from the previous session, which is less than the S&P 500's loss of 0.07% [1] - Over the past month, McKesson's shares have appreciated by 3.83%, outperforming the Medical sector's loss of 1.3% and lagging behind the S&P 500's gain of 3.94% [1] Earnings Estimates - McKesson is expected to report earnings of $8.25 per share on August 6, 2025, reflecting a year-over-year growth of 4.7% [2] - The consensus estimate for revenue is projected at $96.08 billion, indicating a 21.18% increase compared to the same quarter of the previous year [2] Full-Year Projections - The full-year Zacks Consensus Estimates for McKesson are earnings of $37.25 per share and revenue of $405.91 billion, representing year-over-year changes of +12.71% and +13.05%, respectively [3] Analyst Sentiment - Recent changes to analyst estimates for McKesson indicate evolving short-term business trends, with positive revisions suggesting optimism about the business outlook [3][4] Zacks Rank - McKesson currently holds a Zacks Rank of 2 (Buy), with the Zacks Consensus EPS estimate shifting 0.16% upward over the past month [5] Valuation Metrics - McKesson's Forward P/E ratio is 19.74, which is a premium compared to the industry average Forward P/E of 18.21 [6] - The company has a PEG ratio of 1.47, while the Medical - Dental Supplies industry average PEG ratio is 1.67 [6] Industry Context - The Medical - Dental Supplies industry, part of the Medical sector, has a Zacks Industry Rank of 29, placing it in the top 12% of over 250 industries [7]